Is Alzheimer's disease, relentless and slow, a better target for clinical trials?

Published Date: 16 Feb 2023

According to a report by the Alzheimer's Association task force, it's time to reframe what "clinically meaningful" means and change expectations about clinical trials.

Read Full News

Latest News

Hearing Checks Boost Detection of Cytomegalovirus in Infants

The findings underscore why many experts are still pushing for universal screening.

First MS Mobility Drug Gets Green Light From NHS England

NHS England reverses a 2022 NICE rejection now fampridine is off patent, bringing England into line with the rest of the UK.

Why Oropouche Virus Is Gaining Global Attention

Researchers report rapid spread, widespread underdiagnosis, and growing travel-associated infections, raising concerns about future outbreaks beyond Latin America.

Pharmacies Left Out as Pubs Get Rates Cut

Pharmacy associations criticise the government's decision to offer another business rates cut to pubs and live music venues while excluding high street pharmacies again.

A Blood Test for Colon Cancer Screening? Not So Fast!

Dr Aasma Shaukat says that the convenience of a blood test for colorectal cancer should not outweigh the performance of a blood test, especially when weighed against the other options available.

To Treat or Not to Treat? The COVID Conundrum

A 31-year-old presents with COVID and wants medication to fight the infection. Dr Chuck Vega weighs in on the evidence for standard-risk patients.

Todays Updates

Glioma Outcomes Shaped by Subtype More Than Tx Sequence

In high-risk low-grade glioma, starting with temozolomide or radiotherapy yields similar survival.

Stem Cell Transplant Associated With Better PFS in NKTCL

Researchers aim to evaluate the effectiveness of ASCT as consolidation therapy for patients with advanced-stage natural killer/T-cell lymphoma who have attained their first complete remission.

Todays Updates

Glioma Outcomes Shaped by Subtype More Than Tx Sequence

In high-risk low-grade glioma, starting with temozolomide or radiotherapy yields similar survival.

Stem Cell Transplant Associated With Better PFS in NKTCL

Researchers aim to evaluate the effectiveness of ASCT as consolidation therapy for patients with advanced-stage natural killer/T-cell lymphoma who have attained their first complete remission.

Latest News

The findings underscore why many experts are still pushing for universal screening.

NHS England reverses a 2022 NICE rejection now fampridine is off patent, bringing England into line with the rest of the UK.

Researchers report rapid spread, widespread underdiagnosis, and growing travel-associated infections, raising concerns about future outbreaks beyond Latin America.

Pharmacy associations criticise the government's decision to offer another business rates cut to pubs and live music venues while excluding high street pharmacies again.

Dr Aasma Shaukat says that the convenience of a blood test for colorectal cancer should not outweigh the performance of a blood test, especially when weighed against the other options available.

A 31-year-old presents with COVID and wants medication to fight the infection. Dr Chuck Vega weighs in on the evidence for standard-risk patients.

News All Time

At-Home Lecanemab: ‘Encouraging’ First Data

Early real-world data suggest that weekly at-home subcutaneous lecanemab may offer a feasible alternative to ongoing IV maintenance treatment for early Alzheimer’s disease.

Adult-Gerontology Nursing the Future of Elder Care

Adult-gerontology nurse practitioners might be the future of elder care as opportunities grow.

CSF Biomarker Panel May Improve Diagnosis of CNS Lymphoma

A prospective multicenter study validates three cerebrospinal fluid biomarkers that may aid diagnosis of suspected primary CNS lymphoma.

Health Data Platform Connects Hospitals Across Provinces

The VITAL system collects near real-time hospital data with the aim of optimizing healthcare delivery, research, and innovation while protecting privacy.

Focal Therapy Shows Favorable Long-Term Outcomes

A large registry study finds low 10-year prostate cancer mortality after focal HIFU or cryotherapy, but experts caution randomized comparisons with standard treatments are needed.

Blood Test Flags Gynaecologic Cancer Risk in NHS Trial

A blood test correctly flags 99% of gynaecologic cancers as high risk in the largest NHS AI triage trial yet.

Parental Anxiety Persists Up to 2 Years After NICU Discharge

Parents of extremely premature infants show higher anxiety levels well beyond hospital discharge.

Holmium Enucleation Safe for Recurrent Prostatic Obstruction

Holmium laser enucleation of the prostate appears safe and effective for patients who have recurrent benign prostatic obstruction.

Noncardia Gastric Cancer Risk Higher in Some Ethnic Groups

Hispanic and Asian populations in the US show a clinically meaningful risk for noncardia gastric cancer up to two decades earlier than non-Hispanic White populations.

High Suspicion for Cyclosporiasis Needed, Tracing Continues

With the outlines shifting in the current outbreak, testing for the parasite is a no-brainer, say experts.

Fecal Biomarkers Distinguish Pediatric IBD From Diarrhea

Fecal eosinophil-derived neurotoxin, lipocalin-2, and calprotectin are elevated in pediatric IBD, with calprotectin best distinguishing IBD from acute diarrhea, a recent study shows.

First Evidence That Targeting Tau May Slow Cognitive Decline

The investigational drug diranersen led to tau reduction with the lowest dose showing the most consistently positive clinical effect.

Health Disparities and Access Barriers in GAD Care

Matthew Macaluso, DO, comments on systemic barriers that delay GAD diagnosis, highlighting the need for better access to psychiatric care and integrated treatment pathways.

Lecanemab for AD Shows Sustained Benefit in Real-World Study

Real-world data suggest lecanemab’s safety and efficacy mirror results from the pivotal Clarity AD trial and highlight the growing use of blood-based biomarkers in clinical practice.

Chemo Tied to Longer Survival After Pelvic Exenteration

A retrospective international study suggests adjuvant chemotherapy is associated with longer survival after pelvic exenteration in patients with high-risk gynecologic cancers.

When the Algorithm Knows the Risk but Misses the Fear

AI may flag low clinical risk, but it can still miss the patient’s fear, story, and lived experience.

Recommended News For You

Adjuvant Combination for Kidney Cancer Gets FDA's Blessing

Study: For predicting breast cancer, AI performs better than traditional risk models.

'Ticking Time Bomb'; Jimmy Carter's Lasting Impact on Cancer; Breast Cancer-CVD Link

Base Treatment Decisions in Metastatic Breast Cancer on Presence of ESR1 Mutations

Use of marijuana and alcohol simultaneously is associated with worse outcomes.

Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC

Annual whole-body, low-dose CT aids management of smoldering multiple myeloma

Recommended Articles For You

Erythrocyte Functional Impairment During Critical Illness: Mechanisms, Clinical Implications, and Management 

Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers 

Essential Techniques in Oncology and Quality Improvement 

Multiple Primary Lung Cancer: Multidisciplinary Advances in Diagnosis and Care 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Can MRI Curb Chemo Overtreatment in Breast Cancer?

2.

Lymph node transfer reduces arm swelling after breast cancer surgery, study shows

3.

EHA: European Hematology Association

4.

BMTs that are "half-matched" are effective in treating severe sickle cell disease.

5.

Stem Cell Selection Unneeded for SSc Transplant Therapy?

1.

Exploring the Mystery of Angiokeratomas on Scrotum: Causes, Symptoms and Treatment

2.

Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment

3.

Unlocking a New Era in Bladder Cancer Treatment: A Review of the TAR-200 Intravesical Drug Delivery System

4.

Strategic Deals and FDA Approvals Transforming U.S. Oncology Drug Development

5.

Comprehensive Applications in Hematology for Better Care

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

2.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

5.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot